You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

In Ireland, only Bexsero is indicated for MenB vaccination starting from 2 months of age, including infants, toddlers, children, adolescents and adults.

Click to learn more about Bexsero

Vaccines Stock Update

Find out information on the current stock levels of our vaccines.

Vaccines Stock Update

Coming Soon

Coming Soon

Adverse events should be reported to the Health Products Regulatory Authority (HPRA) using an Adverse Reaction Report Form obtained either from the HPRA or electronically via the website at www.hpra.ie. Adverse reactions can also be reported to the HPRA by calling: (01) 6764971. Adverse events should also be reported to GlaxoSmithKline on 1800 244 255

Bexsero is a registered trademark of the GlaxoSmithKline Group of Companies